Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population
Van de Wyngaert, Zoe, Carpentier, Benjamin, Pascal, Laurent, Lionne‐Huyghe, Pauline, Leduc, Isabelle, Srour, Micha, Vasseur, Michele, Demarquette, Helene, Terriou, Louis, Herbaux, Charles, Manier, SalLanguage:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16282
Date:
November, 2019
File:
PDF, 149 KB
english, 2019